AW
Arndt Weinmann

Elite Scholar

374
Works
8,110
Citations
43
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Arndt Weinmann

Also known as: A Weinmann, A. Weinmann, A., Weinmann, Arndt Weinmann, Weinmann, A.

374

Total Works

8,110

Citations

43

H-Index

131

i10-Index

Citation & Works Trend by Year
27 years active
Top Research Topics
Hepatocellular Carcinoma Treatment and Prognosis (252) Colorectal Cancer Treatments and Studies (120) Cholangiocarcinoma and Gallbladder Cancer Studies (48) Cancer Immunotherapy and Biomarkers (44) Pediatric Hepatobiliary Diseases and Treatments (39)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Evaluation of early C‐reactive protein kinetics as an early response marker in biliary tract cancer treated with combined chemoimmunotherapy: A multicenter observational study Cancer 0
2026 ALBI ‐6—A Novel Prognostic Score Combining ALBI and Interleukin‐6 in Patients With HCC Treated With Atezolizumab and Bevacizumab Alimentary Pharmacology & Therapeutics 1
2026 Evaluation of the Mainz Lupus Score: a clinical support tool for managing Systemic Lupus Erythematosus Frontiers in Lupus 0
2026 EORTC-1607-GITCG/ABC-09: Open-label first-line, single-arm phase II study of CisGem combined with pembrolizumab in patients with advanced or metastatic biliary tract cancer Translational Oncology 0
2026 Early C-reactive protein kinetics predict outcomes in unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors: a multicenter, observational study comparing different C-reactive protein kinetic definitions Frontiers in Oncology 0
2026 AI-assisted ascites volumetry for prognostic stratification in HCC treated with Atezolizumab/Bevacizumab Cancer Imaging 1
2026 ALBI-6 – Ein neuer prognostischer Score aus ALBI und Interleukin-6 bei Patient*innen mit hepatozellulärem Karzinom unter Atezolizumab und Bevacizumab Zeitschrift für Gastroenterologie 0
2026 Post-Transplant Evaluation of Checkpoint Inhibitor Therapy in Liver Transplant Patients (PEACH): eine retrospektive multizentrische Kohortenstudie zur Therapie mit Immuncheckpoint-Inhibitoren nach Lebertransplantation Zeitschrift für Gastroenterologie 0
2026 Patienten mit MSI-H/dMMR biliären Karzinomen profitieren von einer Checkpointinhibiton: Ergebnisse einer deutschen multizentrischen Real-World Kohorte Zeitschrift für Gastroenterologie 0
2026 Überleben und prognostischer Einfluss von ALBI-Score und PNI beim duktalen Pankreaskarzinom unter palliativer Systemtherapie: eine retrospektive Real-World-Kohortenstudie Zeitschrift für Gastroenterologie 0
2026 Immunoadsorption Versus Sham Treatment for Post-COVID Syndrome: A Randomised Sham-Controlled Crossover Trial The Lancet Regional Health - Europe 3
2026 Long-term results after surgical resection of intrahepatic cholangiocarcinoma before and since the BILCAP era Frontiers in Surgery 0
2026 Validation of Risk Models for Predicting Post‐SVR HCC in Real‐World Surveillance Across Global Geographic Regions Liver International 0
2026 Incidence, patterns and management of complications (90-day-analysis) after liver surgery – a single center experience with 3177 consecutive hepatic resections Langenbeck s Archives of Surgery 0
2026 Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma—Data From the Multinational LITCHI Registry Liver International 1

Data source: OpenAlex API